ADAI News & Events
January 10, 2025
High Potency Cannabis Leads to ER Visits, Illnesses for Some Users (KUOW with ADAI’s Beatriz Carlini)
This new article from KUOW/NPR describes some of the latest data and research related to serious health impacts from use of high-THC cannabis products and talks to ADAI’s Beatriz Carlini, PhD, MPH, director of our Cannabis Education & Research Program (CERP). The article describes increasing illnesses, ER visits, and deaths related to use of high-THC…
January 8, 2025
Join Us Feb 5 (5:30pm PT) for Our ADAI Research Open House!
Calling all undergraduate students (and others) who are interested in pursuing a career in substance use and addiction research! Join ADAI’s centers, staff, and faculty on February 5, 2025 (5:30-7pm PT) for a virtual ADAI Research Open House where, in addition to sharing overviews of their work, each ADAI center will talk about different research…
Washington Sees Spike in New Chemicals in Street Drugs, Fentanyl (Seattle Times with ADAI’s Caleb Banta-Green)
In this new article from the Seattle Times, ADAI’s Caleb Banta-Green, PhD, MPH, MSW, director of the UW Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER), says that the drug supply in Washington State is increasingly “messy,” with over 237 unique substances (some drugs, some not) found in 816 samples tested in just 6…
January 6, 2025
ADAI Highlights from 2024
HAPPY NEW YEAR from all of us at ADAI! ADAI had an extremely productive 2024, with tons of incredible work from our centers and teams and the development of a very exciting strategic plan that will help shape our future. As we start looking ahead, we first wanted to take a quick peek back at…
December 20, 2024
WATCH: What’s the Latest: Assessment & Treatment of Alcohol Use Disorder (Dec. 2024 webinar)
Alcohol use disorder (AUD) affects millions of individuals and remains one of the leading causes of preventable death worldwide. Despite its prevalence, AUD is often underdiagnosed and undertreated. This webinar from the UW ADAI State Opioid Response Team (SOR) will explore the importance of assessing and treating AUD and provide an overview of the evidence…
December 18, 2024
New ADAI Articles: Pharmacy Staff and Naloxone & PReP Use by MSM Who Use Substances
Two new papers by ADAI researchers and colleagues are now available! Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chains. Green TC, Silcox J, Bolivar D, Gray M, Floyd AS, et al. J Amer Pharm Assoc 2024;64(1):71-78. [subscription access] This paper…
December 16, 2024
Northwest ATTC webinar: Eliminating Hepatitis C (Jan 22, 12pm PT)
Join the Northwest Addiction Technology Transfer Center (ATTC) at the UW Addictions, Drug & Alcohol Institute on January 22, 2025 (12-1pm PT) to learn about Hepatitis C from the Executive Director of the Hepatitis Education Project (HEP), Apoorva Mallya! Mallya will be talking about the prevalence of Hepatitis C virus (HCV) in the U.S., a…
December 9, 2024
ADAI Lunch & Learn: Pipe Distribution Through a Syringe Services Program to Reduce Higher Risk Drug Consumption (Jan 16, 12pm PT)
Join ADAI and presenter Tom Fitzpatrick, MD (UW Physician & Infectious Diseases Fellow) for our next ADAI Lunch & Learn! In this session, Dr. Fitzpatrick will present interim results from his ADAI Small Grants Project. Heroin, fentanyl, methamphetamine, and cocaine can be injected or smoked. Distributing pipes may encourage people who use drugs (PWUD) to…
December 3, 2024
What’s New in Harm Reduction Research (December 2024)
A review of recently published research on harm reduction topics – December 2024. Need help getting copies of any of these articles? Email Meg Brunner, MLIS (meganw@uw.edu). Free articles have “(open access)” after the titles; all other articles require a subscription to access. Facilitators and barriers to monitoring and evaluation at syringe service programs. (open access)…
November 14, 2024
New from CERP Director Beatriz Carlini: Report & Recommendations of the High Potency Cannabis Think Tank to the State of California
ADAI’s Cannabis Education & Research Program Director Beatriz Carlini, PhD, MPH is one of the co-authors of a new report: “Report and Recommendations of the High Potency Cannabis Think Tank to the State of California.” This report was prepared by a committee of scientists (including Dr. Carlini) and medical experts convened by the California Department…
Previous page Next page
